Trade AstraZeneca ^AZN

Top Pharmaceutical Stocks Worth Watching - August 14th - Stock Observer

Global Drugmakers Investment: Global Drugmakers Invest $500 Billion to Enhance U.S. Manufacturing and Research, ETBrandEquity

Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?

Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story?

AZN: Pipeline Strength And 2030 Revenue Ambition Will Drive Re Rating

Will AstraZeneca Have to Pay Medical Expenses for Woman Injured During COVID Vaccine Trial?

Leave no one behind: optimizing kidney protection in type 1 diabetes

Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript

Mineralys Therapeutics Inc (MLYS) (Q2 2026) Earnings Call Highlights: Strong Cash Position and ...

Beyond the Scalpel: how the PROTEUS trial redefines the role of the radical prostatectomy

AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn't Buy This Merger Talk

Hedge Funds are Bullish on AstraZeneca PLC (AZN)

A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?

Lupin gets FDA nod for hyperkalemia drug

Astrazeneca Plc $AZN Shares Sold by NewEdge Advisors LLC

FY2026 EPS Estimates for Astrazeneca Cut by Erste Group Bank - Daily Political

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer

From RAS inhibitor resistance to rational combination strategies

Can AstraZeneca (AZN) Reach Its $80 Billion Revenue Goal Despite Clinical Setbacks?

Jim Cramer Highlights Pharmaceutical Giants as Non-Tech Innovation Plays Like JNJ and LLY

Lupin Gets FDA Approval for Hyperkalemia Drug | Morningstar

21 New 4-Star Stocks This Week | Morningstar

Global drugmakers invest billions to boost U.S. presence

Fasenra® (benralizumab) now approved in Canada for hypereosinophilic syndrome

Promising Pharmaceutical Stocks To Watch Now - August 10th - Daily Political

FY2027 EPS Estimates for Astrazeneca Reduced by Analyst

Type 2 diabetes prevention across the life course

Sun Pharmaceutical Industries Ltd Futures Share Price & Chart Today | IIFL Capital

Goldman Sachs Sticks to Its Buy Rating for Genmab A/S (0MGB)

Oliver Luxxe Assets LLC Purchases New Position in Astrazeneca Plc $AZN

Beacon Investment Advisory Services Inc. Invests $767,000 in Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Sold by FNY Investment Advisers LLC - Daily Political

Manufacturing Stocks To Follow Today - August 8th - Markets Daily

Gradient Investments LLC Makes New Investment in Astrazeneca Plc $AZN

161,624 Shares in Astrazeneca Plc $AZN Acquired by Professional Advisory Services Inc.

Parallel Advisors LLC Invests $1.72 Million in Astrazeneca Plc $AZN - Zolmax

Parallel Advisors LLC Purchases New Position in Astrazeneca Plc $AZN

AstraZeneca's (AZN) "Sell" Rating Reiterated at Deutsche Bank Aktiengesellschaft - Markets Daily

Chesley Taft & Associates LLC Invests $15.41 Million in Astrazeneca Plc $AZN

Cooper Financial Group Buys New Position in Astrazeneca Plc $AZN

The FTSE 100's close to a record high. Does this mean a stock market crash is coming?

Professional Advisory Services Inc. Buys New Stake in Astrazeneca Plc $AZN - Stock Observer

Community Trust & Investment Co. Makes New $17.27 Million Investment in Astrazeneca Plc $AZN - Daily Political

Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma

AstraZeneca (LSE:AZN) Merger Talk Fades, Is The Stock Undervalued?

Assenagon Asset Management S.A. Buys 422,866 Shares of Astrazeneca Plc $AZN - Markets Daily

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN | Morningstar

Sun Pharmaceutical Industries Ltd Option Chain & Strike Prices | IIFL Capital

AI-based augmentation of oncology clinical trials

The dynamic spectrum of steatotic liver disease: the global perspective

Artificial intelligence in drug discovery - what it is, where we stand and the path forward

North American Morning Briefing: Nasdaq Futures Slip on AI Anxiety | Morningstar

Tlwm Makes New $1.76 Million Investment in Astrazeneca Plc $AZN

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

180 Wealth Advisors LLC Invests $3.89 Million in Astrazeneca Plc $AZN

High-Stakes 100-Billion-Yuan Mega Investment Gamble Unfolds: What's Next for the Trillion-Scale Economic Bet?

AstraZeneca and Bristol Myers Squibb: No Ongoing Merger Discussions Confirmed, ETPharma

AstraZeneca, Jaguar Land Rover join UK push to lure talent away from US

AstraZeneca's (AZN) "Buy" Rating Reiterated at Jefferies Financial Group - Daily Political

Astrazeneca (NYSE:AZN) Sees Large Volume Increase - Here's What Happened

SOPHiA GENETICS (NASDAQ:SOPH) Hits New 52-Week High After Analyst Upgrade - Markets Daily

SOPHiA GENETICS (NASDAQ:SOPH) Reaches New 1-Year High After Analyst Upgrade - Zolmax

AstraZeneca and Bristol Myers Squibb merger talks denied

Astrazeneca Plc (NYSE:AZN) Plans Dividend of GBP 0.80

Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

BTIG Research Issues Positive Forecast for SOPHiA GENETICS (NASDAQ:SOPH) Stock Price - Zolmax

Deutsche Bank Aktiengesellschaft Reiterates Sell Rating for AstraZeneca (LON:AZN) - Daily Political

Harvard Student Consultants Log 400 Hours and Party With Snakes

Astrazeneca Plc (AZN) to Issue Dividend of GBP 0.80 on September 8th - Daily Political

SOPHiA GENETICS (NASDAQ:SOPH) Price Target Raised to $9.00 at BTIG Research - Daily Political

Eastern Bank Purchases Shares of 6,092 Astrazeneca Plc $AZN - Daily Political

Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group

AstraZeneca-BMY megadeal talk sparks huge market rift

SOPH Stock Heads For Best Day In Over 8 Months - What's Driving Today's Super Rally?

Brokers split on AstraZeneca merger talk as shares recover some ground

Most big businesses bought zero new petrol or diesel cars for their fleets last year, report reveals

SOPHiA GENETICS Collaborates With AstraZeneca To Develop Precision Oncology Companion Diagnostics

Hilltop National Bank Invests $1.44 Million in Astrazeneca Plc $AZN

Pharmaceutical Stocks Worth Watching - August 4th - Daily Political

Hilltop National Bank Buys Shares of 7,577 Astrazeneca Plc $AZN - Stock Observer

Why Did AMZN, SNOW, BMY Stocks Surge To 52-Week Highs Today?

UK's AstraZeneca eyeing $400b merger, report says - World - Chinadaily.com.cn

Navigating evidence-based recommendations for the management of systemic sclerosis

International Business: AstraZeneca shares fall on merger talks

Advances in the treatment of eosinophilic granulomatosis with polyangiitis

European shares start August higher on US-Iran diplomacy hopes

Amazon joins US$3t market cap club as cheaper oil buoys market

The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today